[1] Hutchins NA,Unsinger J,Hotchkiss RS,et al.The new normal: immunomodulatory against sepsis immune suppression[J].Trends Mol Med,2014,20(4):224-233.
[2] Martin GS.Sepsis,severe sepsis and septic shock:changes in incidence,pathogens and outcomes[J].Expert Rev Anti Infect Ther,2012,10(6):701-706.
[3] 中华医学会重症医学分会.中国严重脓毒症/脓毒性休克治疗指南(2014)[J].全科医学临床与教育,2015,13(4):365-367.
[4] 代传扬,谢兴宇,江元琼.严重脓毒症和脓毒性休克患者早期集束化治疗依从性调查[J].贵州医药,2016,40(4):417-419.
[5] 白冰心,吴言为,张路瑶,等.脓毒症的免疫治疗进展[J].中国新药与临床杂志,2015,34(3):161-166.
[6] 韦茵,吕光宇,蒋文芳,等.胸腺肽联合血必净注射液对老年脓毒症患者炎症状态及免疫功能的影响[J].实用临床医药杂志,2016,20(13):70-72. |
